Institute for Regenerative Medicine

Our research projects

Many of our therapies grew out of observational studies in our own practice. Over many years, we carefully documented what helps our patients and used these findings to develop our treatments further.

But observation alone is not enough. We want to back up what we see in practice with scientific evidence. That is why we founded the Institute for Regenerative Medicine.

Here we coordinate all our research projects, whether completed, ongoing or planned. We analyse our results, design new studies and critically assess what works and what does not.

You benefit directly: what we learn through research informs your treatment.

CITAK – Orthopaedics. As individual as you are.

Neuroregeneration

TPS for dementia

Analysis in progress

We are analysing the treatment courses of our patients with dementia since 2022, looking separately at mild, moderate and severe stages. The findings have already been presented in a specialist lecture. A scientific publication is in preparation.

TPS for Parkinson’s disease

Planned

In our own study, we will examine how symptoms in people with Parkinson’s disease change with transcranial pulse stimulation (TPS), using structured assessments before and after treatment.

TPS for long COVID

Planned

We will investigate whether TPS can help with neurological symptoms after COVID, such as difficulty concentrating or fatigue.

Neuro-COVID and ME/CFS

Planned

A study of neuroregenerative therapies for neurological effects following COVID and for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Participants will record their own data digitally. We aim to collaborate with university partners.

Back and spine

Back pain study in our practice

Ongoing

We systematically document how back pain changes under our treatment approach. The findings provide a basis for larger studies.

RÜCKENPFAD

In planning

A large randomised clinical study with around 300 participants to evaluate a structured care pathway for back pain. Our partner is the spinal surgery department of Hannover Medical School (MHH, Annastift).

Robot-assisted spinal injections

Analysis in progress

We are analysing the outcomes of around 200 patients who received nerve root injections with the help of a navigation robot, focusing on pain and return to work.

Accuracy of robot-assisted needle guidance

Analysis in progress

In a laboratory study, we examined how accurately a navigation robot places needles depending on needle thickness, angle and operator experience. A comparison with the freehand technique will be added.

Head, jaw and neck

Migraine and the neck

Planned

Tight shoulder and neck muscles contribute to triggering many headaches that are considered migraines. We will investigate how much targeted treatment of these muscles helps affected patients.

Headache, migraine and cluster headache

Analysis and planning in progress

In the first part, we are analysing the outcomes of our treatment at the back of the head, which combines local anaesthesia with microcurrent neuromodulation. In the second part, we will compare two treatments directly in a randomised study.

Why dizziness, tinnitus or headache?

Ongoing

The same structures in the neck can trigger tinnitus in one person, dizziness in another and headaches in someone else. We are investigating which pre-existing factors, such as hearing problems, determine which symptoms occur.

Tinnitus and the neck

Planned

In an observational study involving 20 to 30 patients, we will investigate how tinnitus changes during treatment of the neck and jaw.

Trigeminal neuralgia

Idea

We are considering a study of microcurrent neuromodulation for facial pain caused by trigeminal neuralgia, an area with very few controlled studies to date.

Digital health

Patient app

In development

We are developing an app to help people with musculoskeletal symptoms find the right help more quickly. It will offer an initial assessment, suitable exercises to do on their own and clear guidance on when to see a doctor immediately. We will evaluate its effectiveness in our own study with around 200 participants.